Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of XC8 in Healthy Volunteers
NCT03441815Phase 1Completed
- Sponsor
- PHARMENTERPRISES LLC
- Start
- Feb 2015
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of histamine glutarimide in asthma (5 arms), sponsored by PHARMENTERPRISES LLC. Primary endpoints: Number of Adverse events per treatment arm, Physical examination findings and 1 more. Started Feb 2015; status: completed.
02
Drugs
histamine glutarimide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03441815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03441815.